These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4185877)

  • 1. [Effect of trans-AMCHA (trans-aminomethylcyclohexanecarboxylic acid) on fibrinolytic activity].
    Leube G; Kuehn JJ
    Med Welt; 1969 Aug; 34():1846-50. PubMed ID: 4185877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intestinal absorption, distribution and elimination of 4-aminomethylcyclohexanecarboxylic acid (AMCHA) and epsilon-aminocaproic acid (ACA) in humans].
    Kaller H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):160-8. PubMed ID: 4232998
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on an antifibrinolytic agent trans-AMCHA.
    Sunada T; Shimizu H; Morimoto S; Shigemoto H; Fujiyama N
    Acta Med Okayama (1952); 1968 Dec; 22(6):331-7. PubMed ID: 4240920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism of fibrinogen following administration of brain phospholipids in combination with an antifibrinolytic agent (AMCHA)].
    Cultrera G; Lampugnani P
    Arzneimittelforschung; 1973 Mar; 23(3):445-7. PubMed ID: 4740135
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the use of AMCHA in the prevention and correction of hyperfibrinolysis in prostate surgery].
    Consoli C; Di Grazia G; Terranova R; Lanzafame A
    Minerva Urol; 1969; 21(6):214-23. PubMed ID: 4104301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of tissue penetrability and therapeutic dose of epsilon-aminocaproic acid, AMCHA and trasylol with the help of direct homogenate- plasma-thromboelastography examplified on the fibrinolytically active myometrium].
    Schmidt-Matthiesen H; Schreinert B
    Klin Wochenschr; 1968 Jul; 46(13):730-1. PubMed ID: 5306518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tranexamic acid, a new antifibrinolytic agent].
    Kjellman H; Schannong M
    Nord Med; 1970 Feb; 83(6):166-8. PubMed ID: 4910677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical-pharmacological studies on synthetic antifibrinolytic agents].
    Markwardt F; Klöcking HP; Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):78-83. PubMed ID: 4189376
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect on hemophilia by AMCHA].
    Gebauer D; Heigel K
    Med Klin; 1969 Feb; 64(9):378-82. PubMed ID: 5305740
    [No Abstract]   [Full Text] [Related]  

  • 13. On the action mechanism of some fibrinolysis inhibitors.
    Donner L; Housková J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):439-46. PubMed ID: 4952977
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of aminomethylcyclohexane carboxylic acid on the behavior of erythrocytes injected intraperitoneally.
    Koenig AJ; Celander DR; Pratt H
    J Am Osteopath Assoc; 1968 May; 67(9):1063-4. PubMed ID: 5185806
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of an experimentally induced radiation syndrome in the rat using brain phospholipids and an antifibrinolytic agent (AMCHA)].
    Spreafico PL; Galetti G; Cuttin S
    Arzneimittelforschung; 1973 Mar; 23(3):441-4. PubMed ID: 4740134
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicinal chemical studies on antiplasmin drugs. 4. Chemical modification of trans-4-aminomethylcyclohexanecarboxylic acid and its effect on antiplasmin activity.
    Okano A; Inaoka M; Funabashi S; Iwamoto M; Isoda S
    J Med Chem; 1972 Mar; 15(3):247-55. PubMed ID: 5059209
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-inflammatory effect of antiplasmin agents, -aminocaproic acid and trans-4-aminomethyl-cyclohexane carboxylic acid, in rats.
    Yamasaki H; Tsuji H; Kitamura M
    Acta Med Okayama (1952); 1970 Oct; 24(5):509-25. PubMed ID: 4256470
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of reptilase on respiratory insufficiency induced by intravenous infusion of thrombin and AMCA (tranexamic acid) in the dog.
    Busch C; Lindquist O; Saldeen T
    Bibl Anat; 1973; 12():254-9. PubMed ID: 4790359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.